India’s COVID-19 Tally Rises To 10,871,294 As New Cases Per Day See Rise

India’s COVID-19 Tally Rises To 10,871,294 As New Cases Per Day See Rise

NEW DELHI, Feb 11 (NNN-PTI) – India’s COVID-19 tally rose to 10,871,294 today, as 12,923 new cases were registered during the past 24 hours.

According to official data, the death toll mounted to 155,360, as 108 patients died since yesterday morning.

This is the first day in the past several weeks, when the number of new cases shown a rise. Only two days ago, Tuesday, was the first day in several months when less than 10,000 cases were registered.

For the past five consecutive days the number of deaths per day had been below 100.

There are still 142,562 active cases, while 10,573,372 people have been discharged, so far, from hospitals, after medical treatment.

Jan 16 was a crucial day in India’s fight against the pandemic, as the nationwide vaccination drive was kicked off during the day. So far, over seven million people, mainly health workers, have been vaccinated.

Meanwhile, the federal government ramped up testings across the country, even as more than 203 million tests have been conducted so far.

As many as 204,023,840 tests were conducted till yesterday, out of which 699,185 tests were conducted yesterday alone, said the latest data, issued by the Indian Council of Medical Research (ICMR) today.

The national capital Delhi, which has been one of the most affected places in the country, has been witnessing comparatively a lesser number of cases over the past several months. Only 127 new cases and two deaths were registered in the national capital through yesterday.

So far, as many as 10,884 people have died in the capital, confirmed the Delhi’s health department.

Two types of vaccines are being administered to the people in India. While the Covishield vaccine, made by the Serum Institute of India (SII), was supplied to all states, the Covaxin vaccine, made by the Bharat Biotech International Limited, was supplied to only 12 states.– NNN-PTI

administrator

Related Articles